Regenexx Des Moines Overview

  • Founded
  • 2012
  • Status
  • Private
  • Latest Deal Type
  • Angel
  • Latest Deal Amount
  • $2.85M
Latest Deal Amount

Regenexx Des Moines General Information


Developer of patented orthopedics procedure designed to reduce orthopedic costs and achieve better patient outcomes. The company has developed many processing and treatment techniques and has published roughly half of all research world-wide on the use of mesenchymal stem cells for the treatment of orthopedic injuries, enabling physicians to treat orthopedic injuries.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Primary Industry
Other Healthcare Services
Primary Office
  • 9035 Wadsworth Pkwy
  • Suite 1000
  • Westminster, CO 80021
  • United States
+1 (855) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Regenexx Des Moines Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Angel (individual) 04-Dec-2014 $2.85M 00.000 Completed Startup
To view Regenexx Des Moines’s complete valuation and funding history, request access »

Regenexx Des Moines Executive Team (4)

Name Title Board Seat Contact Info
Jason Hellickson Chief Executive Officer
Christopher Centeno MD Chief Medical Officer
Michael Vasquez Executive Officer & Board Member
You’re viewing 3 of 4 executive team members. Get the full list »

Regenexx Des Moines Board Members (1)

Name Representing Role Since
Michael Vasquez Self Executive Officer & Board Member 000 0000
To view Regenexx Des Moines’s complete board members history, request access »